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Abstract: Interactions of nanoparticles with biomaterials determine the biological activity that is
key for the physiological response. Dendritic polyglycerol sulfates (dPGS) were found recently
to act as an inhibitor of inflammation by blocking selectins. Systemic application of dPGS would
present this nanoparticle to various biological molecules that rapidly adsorb to the nanoparticle
surface or lead to adsorption of the nanoparticle to cellular structures such as lipid membranes. In
the past, fluorescence lifetime measurements of fluorescently tagged nanoparticles at a molecular
and cellular/tissue level have been proven to reveal valuable information on the local nanoparticle
environment via characteristic fluorescent lifetime signatures of the nanoparticle bound dye. Here,
we established fluorescence lifetime measurements as a tool to determine the binding affinity to
fluorescently tagged dPGS (dPGS-ICC; ICC: indocarbocyanine). The binding to a cell adhesion
molecule (L-selectin) and a human complement protein (C1q) to dPGS-ICC was evaluated by the
concentration dependent change in the unique fluorescence lifetime signature of dPGS-ICC. The
apparent binding affinity was found to be in the nanomolar range for both proteins (L-selectin:
87 ˘ 4 nM and C1q: 42 ˘ 12 nM). Furthermore, the effect of human serum on the unique
fluorescence lifetime signature of dPGS-ICC was measured and found to be different from the
interactions with the two proteins and lipid membranes. A comparison between the unique lifetime
signatures of dPGS-ICC in different biological environments shows that fluorescence lifetime
measurements of unique dPGS-ICC fluorescence lifetime signatures are a versatile tool to probe
the microenvironment of dPGS in cells and tissue.
Keywords: nanomedicine; dendritic polymers; protein corona; fluorescence lifetime
1. Introduction
The molecular basis of nanoparticle interactions with cells and tissue can only be understood
with precise knowledge of molecular properties of the nanoparticle. This characterization is of
paramount importance, especially with regard to the targeted delivery of drugs or the physiological
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action of the nanoparticle itself. New and different analytical methods have to be established to meet
the needs of the rapidly growing field of nanomedicine [1–4].
Important properties of dendrimeric nanoparticles like dendritic polyglycerol sulfates
(dPGS) [5–10] include the size, shape and flexibility of the nanoparticle [11]. In a recent report
we showed that both size and conformational flexibility of dPGS depend on temperature [1]. The
fluorescent indocarbocyanine (ICC) (Figure 1) tag proved to be an efficient sensor for environmental
properties as shown by the different fluorescence lifetimes in a systematic study of dPGS-ICC in
different aqueous and organic solvents [1]. In addition to being dependent on the polarity [3], the
fluorescence lifetime of the ICC dye is also sensitive to steric restrictions (Figure 1). In aqueous
environments the ICC methine linker can rotate freely, leading to the short fluorescence lifetime
of about 0.15 ns of the fluorophore. Steric hindrance of the ICC methine linker results in longer
lifetimes [1–3,12]. A longer lifetime component of about 1 ns was observed for ICC bound to dPGS [2]
(Figure 1A, Table 1). Upon binding of dPGS-ICC to lipid membranes an additional 4 ns component
becomes apparent [1] (Figure 1A).
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Figure 1. Structure and fluores nce lifetime char ristics of dPGS-ICC. (A) Fluorescenc lif tim
curves of ICC and dPGS-ICC in water and bound to DMPC lipid membranes; and (B) structural
scheme of dPGS and the bound fluorescent tag ICC. A detailed description of the conjugation
procedure is given by Licha et al. [13].
Upon administration of dPGS, the nanoparticle would interact with proteins of the blood serum
or constituents of biological membranes (e.g., proteins and/or lipids). Interaction of nanoparticles
with proteins is known as the “prot in corona” [4,14] that determines the biological activity of the
respective anoparticle, because proteins compete with the target structures for the nanoparticle
surface [15,16]. In the past several different methods were implemented to study the equilibrium and
kinetic parameters of protein-nanoparticle interactions such as isothermal titration calorimetry (ITC),
gel filtration, size-exclusion chromatography, surface plasmon resonance (SPR), or centrifugation
based pull-down assays [4]. We recently established time-resolved fluorescence spectroscopy
and fluorescenc lifetime imaging microsco y (FLIM) as a versatile tool to analyze nanoparticle
interactio s at the molecular and cell/tissue level [1–3].
Here, we extended our previous fluorescence lifetime studies on dPGS-ICC to
nanoparticle-protein interactions using L-selectin and the complement protein C1q as well as
human serum. We show that fluorescence lifetime methods are well suited to detect the “protein
corona” and to quantify binding affinities of individual proteins. Moreover, we show that different
biomolecules display different fluorescenc d cay parameters underscoring our concept of using
unique fluor scence lifetimes as target signatures in FLIM-based analyses of na oparticle interactions
in cells and tissue.
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2. Results and Discussion
2.1. Determination of Apparent Protein Binding Constants for dPGS-ICC
2.1.1. Binding of L-Selectin
We investigated fluorescence lifetime spectroscopy as a tool to determine affinity
of protein–dPGS-ICC interaction. Multivalent dPGS is known to efficiently bind L- and
P-selectin [6,7,9,10]. L-selectin is one of the natural cell adhesion molecules on leukocytes that
in chronic inflammation processes extravasate into inflamed tissue by interactions of L-, E-, and
P- selectins and their corresponding ligands consisting of fucosylated and sialylated glycoproteins
on the endothelium.
First, soluble L-selectin (L-selectin-IgG chimera) was titrated in three different concentrations
into a solution of 0.1 µM dPGS to evaluate whether a change in the fluorescence lifetime curve occurs.
As this was the case we titrated 11 different concentrations into the dPGS-ICC solution until no change
in the fluorescence lifetime curve was observable (Figure 2).
Molecules 2016, 21, 0022 3 of 13 
 
L-selectin is one of the natural cell adhesion molecules on leukocytes that in chronic inflammation 
processes extravasate into inflamed tissue by interactions of L-, E-, and P- selectins and their 
corresponding ligands consisting of fucosylated and sialylated glycoproteins on the endothelium. 
First, soluble L-selectin (L-selectin-IgG chimera) was titrated in three different concentrations into 
a solution of 0.1 µM dPGS to evaluate whether a change in the fluorescence lifetime curve occurs. As 
this was the case we titrated 11 different concentrations into the dPGS-ICC solution until no change 
in the fluorescence lifeti e curve was observable (Figure 2). 
 
Figure 2. Fluorescence lifetime curves of 0.1 µM dPGS-ICC alone and with 11 different concentrations 
of soluble L-selectin-IgG chimera (0.001 µM to 2 µM) in DPBS at 20 °C. 
The fluorescence decay curves were fitted with a multi-exponential decay function and the mean 
fluorescence lifetime was determined. The time-resolved fluorescence method belongs to the indirect 
methods to determine a binding constant. The assumption is made that the measured fluorescence 
lifetime (or better the change upon binding) is directly proportional to the concentration of the 
nanoparticle-bound protein, assuming that the protein exists only in two states, in the nanoparticle 
bound and in the free state, each state having its own unique fluorescence lifetime characteristics. 
To analyze the binding affinity, the difference between the mean fluorescence lifetime at 0 µM 
L-selectin and the mean fluorescence lifetimes at different L-selectin concentrations was calculated. 
The lifetime difference at 2 µM L-selectin constitutes the value at saturation of the binding reaction and 
was set as 100%. To determine the binding affinity the fractional saturation values (lifetime differences 
in %) were plotted vs. the concentration of L-selectin and fitted by a sigmoidal function (Figure 3). 
The half-maximum concentration of L-selectin binding was determined to 87 ± 4 nM with a Hill 
coefficient of n = 1.4 indicating a binding stoichiometry of about 1:1. The fluorescence decay time 
constants of the saturated lifetime signal are summarized in Table 1. 
 
Figure 3. L-selectin-binding curve to 0.1 µM dPGS-ICC in DPBS at 20 °C. The concentrations are 
plotted on a logarithmic scale. The inset shows the data on a linear scale. The half maximum binding 
concentration was determined to be 87 ± 4 nM with a Hill-coefficient of n = 1.4. 
  
Figure 2. Fluorescence lifetime curves of 0.1 µM dPGS-ICC alone and with 11 different concentrations
of soluble L-selectin-IgG chimera (0.001 µ to 2 µ ) in DPBS at 20 ˝C.
The fluorescence decay curves were fitted with a multi-exponential decay function and the mean
fluorescence lifetime was determined. The time-resolved fluorescence method belongs to the indirect
methods to determine a binding constant. The assumption is made that the measured fluorescence
lifetime (or better the change upon binding) is directly proportional to the concentration of the
nanoparticle-bound protein, assuming that the protein exists only in two states, in the nanoparticle
bound and in the free state, each state having its own unique fluorescence lifetime characteristics.
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Figure 3. L-selectin-binding curve to 0.1 µM dPGS-ICC in DPBS at 20 ˝C. The concentrations are
plotted on a logarithmic scale. The inset shows the data on a linear scale. The half maximum binding
concentration was determined to be 87 ˘ 4 nM with a Hill-coefficient of n = 1.4.
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To analyze the binding affinity, the difference between the mean fluorescence lifetime at 0 µM
L-selectin and the mean fluorescence lifetimes at different L-selectin concentrations was calculated.
The lifetime difference at 2 µM L-selectin constitutes the value at saturation of the binding reaction
and was set as 100%. To determine the binding affinity the fractional saturation values (lifetime
differences in %) were plotted vs. the concentration of L-selectin and fitted by a sigmoidal function
(Figure 3). The half-maximum concentration of L-selectin binding was determined to 87 ˘ 4 nM with
a Hill coefficient of n = 1.4 indicating a binding stoichiometry of about 1:1. The fluorescence decay
time constants of the saturated lifetime signal are summarized in Table 1.
2.1.2. Binding of C1q
Second, the complement protein C1q is the first protein that binds to immobilized antibodies
and activates the classical pathway. In addition to its beneficial role in foreign antigen targeting, C1q
plays an important role in autoimmune diseases and triggers inflammation. To study the interaction
with dendritic polyglycerol sulfate C1q was titrated to a solution of 0.1 µM dPGS to evaluate whether
a change in the fluorescence lifetime curve occurs. This was the case and we titrated eight different
concentrations into the dPGS-ICC solution (Figure 4).
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Figure 4. Fluorescence lifetime curves of 0.1 µM dPGS-ICC alone and with eight different
concentrations of the complement protein C1q (0.001 µM to 0.5 µM) in DPBS at 20 ˝C.
Using the fractional saturation method the apparent binding affinity was determined to be
42 ˘ 12 nM for C1q (Figure 5). The Hill coefficient was n = 1.1 indicating also for C1q a 1:1 binding
stoichiometry. The fluorescence decay time constants of the saturated lifetime signal are summarized
in Table 1.
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2.1.3. Binding of Human Serum
Next we tested at which concentration (in %) human serum with a protein content of 53 mg/mL
results in a saturation of the fluorescence lifetime signal. Figure 6A shows the fluorescence lifetime
curves of dPGS-ICC with 0%, 10%, 30%, 50%, and 70% serum concentration. These data clearly show
that already at about 10% serum concentration (equivalent to a 5.3 mg/mL solution) the saturation
fluorescence signal is reached. The fluorescence decay time constants of the saturated lifetime signal
are summarized in Table 1.
To determine the binding affinity of human serum constituents to dPGS we titrated human
serum at different concentrations between 0.001% and 10% serum (Figure 6B). Using the fractional
saturation method, the mean fluorescence lifetime derived data were plotted in percent as a function
of human serum concentration in Figure 6C,D. Analysis of the binding curve gives a mean apparent
binding affinity corresponding to 0.3% serum (with a Hill coefficient n = 1). In contrast to the
plots shown in Figures 3 and 5 the sigmoidal fit (Figure 6D) does not completely fit the data. This
is understandable as the serum consists of a mixture of different proteins which could bind with
different affinities. We thus added a second component to the fit and the resulting apparent binding
affinities (half maximum binding concentration) were 0.2% serum (78% amplitude) and 5% serum
(22% amplitude). Even though there are more than two different proteins in the human serum, the
fit considerably improves. We conclude that dPGS has the potential to bind different protein species
with varying binding affinity. This is an important result as it provides a rationale that, despite its
protein corona, dPGS recognizes L-selectin in living tissue [6].
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Figure 6. dPGS-ICC binding to human serum. (A) Fluorescence lifetime curves of 0.1 µM dPGS-ICC
alone and with 10%, 30%, 50%, and 70% human serum in DPBS at 20 ˝C; (B) Fluorescence decay
curves for titration of dPGS-ICC with human serum at different concentrations between 0.001% and
10% serum; (C,D) Fractional saturation as a function of human serum concentration both linear (C)
and with a logarithmic x-axis (D). The half maximum binding concentration was determined to be
0.3% huma serum (using a Hill-coefficient of n = 1) for a single component fit and 0.2% and 5% for a
double component fit.
2.1.4. SPR Measurements of Protein A sociation
L-selectin binding to dPGS was also investigated by surface plasmon resonance (SPR). The
dPGS was immobilized on a chip and the defined concentrations of the analytes L-selectin and
C1q were passed over the functionalized surface. Binding affinity was determined from resulting
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binding isotherms (Figure 7) and gave values of 45 ˘ 17 nM for L-selectin and 62 ˘ 10 nM for C1q.
These complementary experiments prove that binding of L-selectin and C1q to dPGS determined
by either analysis of fluorescence decay curves or SPR revealed comparable affinities in the lower
nanomolar range.
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2.2.2. Binding Kinetics of L-Selectin 
Next, we determined the binding kinetics of L-selectin (Figure 9A,B). At the saturation 
concentration of 1 µM, L-selectin binds very fast with a time constant of 26 ± 1 s. This is in the same 
range as the binding time constant of 10% serum (Figure 8). Subsequent addition of 10% serum to 
L-selectin saturated dPGS-ICC leads to further increase of the fluorescence lifetime (Figure 9C). 
Evaluation of the kinetics of serum binding to L-selectin saturated dPGS-ICC reveals a bi-exponential 
binding kinetics with time constants of 24 ± 3 s (30% amplitude) and 242 ± 36 s (70% amplitude). This 
is in contrast to the monoexponential binding kinetics with a time constant of 34 s observed for 10% 
serum alone. Clearly, L-selectin competes with the binding of other serum proteins. A comparison of 
the unique lifetime signatures of dPGS-ICC with 10% serum and dPGS with L-selectin/10% serum 
shows subtle but clear differences that indicate the presence of dPGS bound L-selectin under 
Figure 7. Langmuir binding isotherms of L-selectin (A) and C1q (B) to dPGS.
2.2. Determination of Protein Binding Kinetics to dPGS-ICC
2.2.1. Binding Kinetics of Human Serum
Binding kinetics measurements offer an additional approach to evaluate protein association.
We first tested the binding kinetics of different concentrations of human serum. We choose two
concentrations, near the half maximum binding concentration (0.5% serum, Figure 8A) and a
concentration that leads to saturation of the fluorescence lifetime signal (10% serum, Figure 8B).
Figure 8C shows the binding curves. As expected from the fractional binding signal (Figure 6), the
kinetics is faster for 10% serum (34 ˘ 3 s) than for 0.5% serum (77 ˘ 4 s).
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2.2.2. Binding Kinetics of L-Selectin
Next, we determined the binding kinetics of L-selectin (Figure 9A,B). At the saturation
concentration of 1 µM, L-selectin binds very fast with a time constant of 26 ˘ 1 s. This is in the
same range as the binding time constant of 10% serum (Figure 8). Subsequent addition of 10% serum
to L-selectin saturated dPGS-ICC leads to further increase of the fluorescence lifetime (Figure 9C).
Evaluation of the kinetics of serum binding to L-selectin saturated dPGS-ICC reveals a bi-exponential
binding kinetics with time constants of 24˘ 3 s (30% amplitude) and 242˘ 36 s (70% amplitude). This
is in contrast to the monoexponential binding kinetics with a time constant of 34 s observed for 10%
serum alone. Clearly, L-selectin competes with the binding of other serum proteins. A comparison
of the unique lifetime signatures of dPGS-ICC with 10% serum and dPGS with L-selectin/10%
serum shows subtle but clear differences that indicate the presence of dPGS bound L-selectin under
saturating binding concentrations of human blood serum. This result supports our conclusion from
the previous section that dPGS recognizes L-selectin despite the presence of other competing proteins
in blood plasma.
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on the mean fluorescence lifetimes, as a function of time. The value of τ = 26 s was obtained from
an exponential fit to the data (dashed line); (C) Lifetime decay curves of 0.1 µM dPGS-ICC binding to
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Table 1. Fluorescence lifetime parameters for different dPGS-ICC interaction partners according to
Equation (1). The mean fluorescence lifetime (Equation (2)) a d the reduced X2 is give .
Sample α1 (%) τ1 (ns) α2 (%) τ2 (ns) α3 (%) τ3 (ns) τmean (ns) X2R
0.1 µM dPGS-ICC 5.7 1.16 30.7 0.47 63.6 0.17 0.51 1.05
+ 0.5 µM C1q 11.2 1.85 31.3 0.67 57.5 0.18 1.04 0.95
+ 1 µM L-selectin 17.4 1.75 40.5 0.65 42.1 0.19 1.11 1.01
+ 1 µM L-selectin + 10% Serum 37.1 2.24 39.5 0.90 23.4 0.19 1.78 0.91
+ 70% Serum 39.2 2.27 35.1 0.85 25.7 0.14 1.87 0.98
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3. Materials and Methods
3.1. Time-Resolved Fluorescence Setup
All measurements were performed on a time-resolved fluorescence setup [17–19] with a tunable
white light laser source (SuperK Extreme EUV3, NKT, Birkerød, Denmark), a microchannel plate
detector and time-correlated single photon counting (TCSPC) electronics (SPC-830, Becker & Hickl
GmbH, Berlin, Germany) with picosecond time resolution. The excitation of ICC at 530 nm
was selected via an acousto-optical tunable filter (SELECT UV-VIS, NKT, Birkerød, Denmark).
Fluorescence emission was collected above 545 nm using a long-pass filter (HQ545 LP, Chroma,
Bellows Falls, VT, USA). The excitation power was 220 µW and the repetition rate was 19.5 MHz.
The time range was set to 10 ns divided into 1024 channels resulting in a resolution of 9.8 ps/channel.
The instrument response function of the system was ~54 ps full width at half maximum.
3.2. Experimental Procedures
3.2.1. Dendritic Polyglycerol Sulfate Nanocarrier Labeled with a Fluorescent ICC Dye (dPGS-ICC)
Dendritic polyglycerolsulfate (dPGS) with a molecular weight of approx. 12,000 g/mol was
synthesized according to literature via an anionic multi-branching ring-opening polymerization of
glycidol and sulfation using sulfurtrioxide-pyridinium complex [20]. A detailed description of the
dye conjugation procedure is given by Licha et al. [13]. Briefly, to attach ICC to dPGS, an azido-linker
(linker 11-azido-1-undecanyl-tosylate) was conjugated to the polyglycerol scaffold at a molar ratio of
approximately one linker per polymer before sulfation. After sulfation, the azido-containing polymer
was conjugated with a propargyl derivative of ICC by copper-catalyzed 1,3-dipolar cycloaddition
(click conjugation) in water/ethanol. After synthesis, the dPGS-ICC was lyophilized. All experiments
were conducted with a freshly prepared dPGS-ICC sample from the lyophilisate of the same batch.
3.2.2. Determination of Apparent Protein Binding Constants for dPGS-ICC
To determine the apparent protein binding constants for dPGS-ICC, samples containing 0.1 µM
dPGS-ICC and varying concentrations of either L-selectin (L-selectin-IgG chimera, R & D Systems,
Wiesbaden, Germany) or C1q (Fitzgerald Industries International, Acton, MA, USA) were prepared
in DPBS buffer (PAA; 10 mM phosphate, 1 mM calcium, 1 mM magnesium, 3 mM KCl, 137 mM NaCl,
pH 7.4). The measurements were conducted after incubating 0.1 µM dPGS-ICC and the different
protein concentrations for 2 min at room temperature. In addition the binding behavior of dPGS-ICC
in human serum was analyzed. Here, fluorescence lifetime measurements were conducted after
incubating 0.1 µM dPGS-ICC and different concentrations of serum for 5 min at room temperature.
The fluorescence decay was recorded for 180 s.
3.2.3. Determination of Protein Binding Kinetics to dPGS-ICC
To determine the kinetics of dPGS-ICC binding in human serum, a buffer solution containing
dPGS-ICC was prepared. Directly before the start of the measurement human serum was added to
either 10% or 0.5% final concentration. The concentration of dPGS-ICC in the final volume was 0.1 µM
in both cases. The fluorescence decay was recorded over a time period of 15 min, with a duration of
60 s for each individual recording.
3.2.4. Determination of Protein Exchange
To determine the influence of human serum on preincubated L-selectin, first the kinetics of
dPGS-ICC binding to L-selectin were determined and then the effect of human serum addition was
followed. A buffer solution containing dPGS-ICC was prepared. Directly before the start of the
measurement L-selectin was added at a concentration of 1 µM. The concentration of dPGS-ICC in the
final volume was 0.1 µM. The fluorescence decay was recorded over a time period of 14 min, with a
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duration of 60 s for each individual recording. Then, human serum was added, final concentration
10%, and further measurements were conducted for the next 13 min, again with a duration of 60 s for
each individual recording.
3.2.5. SPR Measurements of Protein Association
Experiments were carried out on a Biacore X100 device (GE Healthcare, Freiburg, Germany).
A streptavidin coated chip (SA-Chip, GE Healthcare) was coupled with dPGS-biotin to a level of
~400 resonance units (RU) in HBS-Ca (10mM HEPES pH 7.4 + 150 mM NaCl + 1 mM CaCl2) as a
running buffer using standard procedures. Briefly, the chip was conditioned using three consecutive
injections of 60 s 1 M NaCl + 50 mM NaOH before injection of dPGS-biotin and washing with three
consecutive injections of running buffer. Affinities were measured using a kinetic titration series
(single cycle kinetics) at 25 ˝C in which five ascending concentrations of the analyte (C1q or L-Sel-IgG
chimera) were injected consecutively for 120 s at 30 µL/min followed by a dissociation time of 600
s and one regeneration step with 4 M MgCl2 for 120 s. L-selectin was diluted in HBS-Ca to final
concentrations of 1000, 333, 111, 37, and 12.34 nM; C1q in surfactant P20 supplemented (+0.005%)
running buffer (HBSP) at concentrations of 400, 80, 16, 3.2, and 0.64 nM. The signal of the untreated
flow cell was subtracted from the binding signal. Additionally, blank injects of running buffer only
were also subtracted (double referencing) for each run. Sensorgrams were analyzed by plotting the
analyte concentration against the binding signal at the end of inject. The resulting isotherm was fitted
using the steady state model.
3.3. Data Analysis
3.3.1. Determination of Fluorescence Decay Parameters
The fluorescence decay profiles were analyzed using the software package Globals Unlimited
V2.2 (Laboratory for Fluorescence Dynamics). An algorithm based on a Marquardt–Levenberg type











where ai are the amplitudes and τi are the lifetimes of the ith decay component. αi are the
corresponding relative amplitudes, with αi = ai/
ř
ai [17,21].
3.3.2. Determination of Apparent Binding Constants
To determine the apparent binding constants of dPGS-ICC, the mean lifetime of the respective







i αi ˚ τi
˙
(2)
where αi are the relative amplitudes and τi are the lifetimes of the ith decay component.
The fractional saturation (in %) was determined as follows:






where τmean is the mean lifetime of the respective lifetime decay curve, τ0 is the mean lifetime of the
lifetime decay curve of dPGS-ICC in solution, and τmax is the highest mean lifetime.
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The resulting data points were then fit according to the model function
y pxq “ S ˚ x
n
pK50n ` xnq (4)
where S is the saturation of binding, K50 is the half maximum binding concentration (apparent
binding affinity), and the Hill-coefficient n, a cooperativity factor.
3.3.3. Determination of Protein Binding Kinetics to dPGS-ICC
To determine the binding kinetics of dPGS-ICC, the mean lifetime of the respective fluorescence
decay curves was calculated as described in Equation (2) and the fractional saturation (in %)
was calculated according to Equation (3). The kinetic data was then fit with an exponential
model function.
y ptq “ A ˚ e
t
τ (5)
3.3.4. Determination of Protein Exchange
The binding kinetics of dPGS-ICC to L-selectin were determined as described in 3.3.2. To
evaluate the kinetics of serum addition the fractional saturation (in %) was determined using
Equation (3), however with τ0 the mean lifetime of the lifetime decay curve of dPGS-ICC bound
to L-selectin. The kinetic data required a fit with a biexponential model function according to:
y ptq “ A1 ˚ e
t




dPGS is a multivalent dendritic negatively-charged nanoparticle whose binding affinities are
largely determined by electrostatic interactions. For example binding to L-selectin occurs via a patch
of basic amino acid residues in the lectin binding domain [22]. However, other proteins including
membrane proteins very often feature charged patches that may also undergo transient changes upon
protein function [23–25]. Thus it is very likely that in a physiological environment a plethora of dPGS
binding partners exists. Here, a comparison of the lifetime signatures of dPGS-ICC with different
proteins present in human serum and cellular membranes, like C1q and L-selectin, respectively,
shows clear differences (Figure 10).
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Previously-published data on dPGS-ICC showed that the two fastest decay components reflect
on the polarity of the ICC environment while the slowest component is due to steric hindrance of
the methine linker rotation caused by the PG branches [1]. Here, we observed that both the slowest
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component and the intermediate component show slower lifetime values upon dPGS-ICC binding
to the proteins L-selectin and C1q but also in the presence of human serum, with the exact values
depending on the specific protein. This clearly indicates that the binding of dPGS-ICC to the proteins
L-selectin and C1q, but also to binding partners in human serum, changes both the polarity of the
immediate dPGS-ICC environment and also the steric hindrance for the rotation of the ICC methine
linker in a protein dependent fashion.
The measurements presented in this paper were performed in solution. However, fluorescence
lifetime can also be recorded in a spatial resolved fashion on cells and tissues under a microscope,
i.e., with fluorescence lifetime imaging microscopy (FLIM). The use of FLIM is known to include
environmental sensing of, amongst others, polarity, local pH, and calcium concentrations, as well as
the study of protein interactions in living cells [26]. The results provided in this study show that
the fluorescence lifetime also allows for the environmental sensing of biomolecular interactions with
dPGS, as unique dPGS-ICC lifetimes exist depending on the dPGS binding partner (Figure 10). Thus,
we now extend our concept of using unique fluorescence lifetime signatures for fast and reliable
localization of fluorescently labeled nanoparticles in cellular systems and tissue samples [2,27–30]
to the potential detection of biomolecular interactions of dPGS in physiological environments. The
results presented allow for the possibility of specifically determining the dPGS interaction partners
based on the specific fluorescence signature. Further, this methodology is not necessarily limited
to dPGS, as in theory any nanoparticle with a fluorescent reporter group can be used, as long as
the environmental sensitivity is high enough. However, the use of ICC, as in this study, offers the
additional benefit of being sensitive to the steric hindrance of the dye upon nanoparticle-biomolecule
interactions. This concept will be developed further in future experiments.
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The following abbreviations are used in this manuscript:
dPGS Dendritic polyglycerol sulfate
dPGS-ICC Indocarbocyanine bound to dendritic polyglycerol sulfate
ICC Indocarbocyanine
DMPC Dimyrostoylphosphatidylcholine
ITC Isothermal titration calorimetry
FLIM Fluorescence lifetime imaging microscopy
TCSPC Time-correlated single photon counting
IgG Immunglobulin G
RU Resonance units
SPR Surface plasmon resonance
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